• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Chron Obstruct Pulmon Dis . Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following H

tetano

Editor, Senior Moderator
Int J Chron Obstruct Pulmon Dis


. 2023 Nov 7:18:2473-2481.
doi: 10.2147/COPD.S428316. eCollection 2023. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19

Juan Marco Figueira-Gonçalves[SUP] 1 2 [/SUP], Miguel Ángel García-Bello[SUP] 3 4 [/SUP], Yolanda Ramallo-Fariña[SUP] 3 4 5 [/SUP], Raúl Méndez[SUP] 6 7 8 9 [/SUP], Ana Latorre Campos[SUP] 6 7 [/SUP], Paula González-Jiménez[SUP] 6 7 9 [/SUP], Germán Peces-Barba[SUP] 10 [/SUP], María Molina-Molina[SUP] 11 [/SUP], Pedro Pablo España[SUP] 12 [/SUP], Estela García[SUP] 13 [/SUP], Santiago de Jorge Domínguez-Pazos[SUP] 14 [/SUP], Marta García Clemente[SUP] 15 [/SUP], Carolina Panadero[SUP] 16 [/SUP], David de la Rosa-Carrillo[SUP] 17 [/SUP], Oriol Sibila[SUP] 18 [/SUP], María Dolores Martínez-Pitarch[SUP] 19 [/SUP], Nuria Toledo-Pons[SUP] 20 [/SUP], Cecilia López-Ramirez[SUP] 21 [/SUP], Wanda Almonte-Batista[SUP] 22 [/SUP], Abigail Macías-Paredes[SUP] 23 [/SUP], Diana Badenes-Bonet[SUP] 24 [/SUP], Eli Nancy Pérez-Rodas[SUP] 25 [/SUP], Javier Lázaro[SUP] 26 [/SUP], Sarai Quirós Fernández[SUP] 27 [/SUP], Rosa Cordovilla[SUP] 28 [/SUP], Irene Cano-Pumarega[SUP] 8 29 [/SUP], Antoni Torres[SUP] 8 18 [/SUP], Rosario Menendez[SUP] 6 7 8 9 [/SUP]; RECOVID



Affiliations
Abstract

Background: Chronic obstructive pulmonary disease (COPD) has been associated with worse clinical evolution/survival during a hospitalization for SARS-CoV2 (COVID-19). The objective of this study was to learn the situation of these patients at discharge as well as the risk of re-admission/mortality in the following 12 months.
Methods: We carried out a subanalysis of the RECOVID registry. A multicenter, observational study that retrospectively collected data on severe acute COVID-19 episodes and follow-up visits for up to a year in survivors. The data collection protocol includes general demographic data, smoking, comorbidities, pharmacological treatment, infection severity, complications during hospitalization and required treatment. At discharge, resting oxygen saturation (SpO2), dyspnea according to the mMRC (modified Medical Research Council) scale and long-term oxygen therapy prescription were recorded. The follow-up database included the clinical management visits at 6 and 12 months, where re-admission and mortality were recorded.
Results: A total of 2047 patients were included (5.6% had a COPD diagnosis). At discharge, patients with COPD had greater dyspnea and a greater need for prescription home oxygen. After adjusting for age, sex and Charlson comorbidity index, patients with COPD had a greater risk of hospital re-admission due to respiratory causes (HR 2.57 [1.35-4.89], p = 0.004), with no significant differences in survival.
Conclusion: Patients with COPD who overcome a serious SARS-CoV2 infection show a worse clinical situation at discharge and a greater risk of re-admission for respiratory causes.

Keywords: COPD; COVID-19; RECOVID; SARS-CoV2; SEPAR; Spanish COVID-19 registry; chronic obstructive pulmonary disease; coronavirus disease 2019; respiratory failure; severe acute respiratory syndrome coronavirus 2.

 
Back
Top Bottom